Literature DB >> 12087035

Atorvastatin, diabetic dyslipidemia, and cognitive functioning.

Ingrid Berk-Planken, Inge de Konig, Ronald Stolk, Hans Jansen, Nicoline Hoogerbrugge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12087035     DOI： 10.2337/diacare.25.7.1250

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  8 in total

Review 1.  Current drug treatment of hyperlipidemia in older adults.

Authors:  Dave L Dixon; Krista L Donohoe; Kelechi C Ogbonna; Sarah M Barden
Journal:  Drugs Aging       Date:  2015-02       Impact factor: 3.923

Review 2.  Cognitive effects of statin medications.

Authors:  Brendan J Kelley; Stephen Glasser
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

Review 3.  Do the frequencies of adverse events increase, decrease, or stay the same with long-term use of statins?

Authors:  Karlyn Huddy; Pavittarpaul Dhesi; Paul D Thompson
Journal:  Curr Atheroscler Rep       Date:  2013-02       Impact factor: 5.113

Review 4.  Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials.

Authors:  Brian R Ott; Lori A Daiello; Issa J Dahabreh; Beth A Springate; Kimberly Bixby; Manjari Murali; Thomas A Trikalinos
Journal:  J Gen Intern Med       Date:  2015-01-10       Impact factor: 5.128

Review 5.  Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors:  Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

6.  Patterns of relationships between cardiovascular disease risk factors and neurocognitive function in African Americans.

Authors:  Regina Sims; Serge Madhere; Clive Callender; Alfonso Campbell
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

7.  Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study.

Authors:  Masahito Takagi; Yasushi Ishigaki; Kenji Uno; Shojiro Sawada; Junta Imai; Keizo Kaneko; Yutaka Hasegawa; Tetsuya Yamada; Ai Tokita; Kazumi Iseki; Shigenori Kanno; Yoshiyuki Nishio; Hideki Katagiri; Etsuro Mori
Journal:  BMC Neurol       Date:  2013-07-09       Impact factor: 2.474

8.  A review of the potential therapeutic role of statins in the treatment of Alzheimer's disease: current research and opinion.

Authors:  Alvaro Sánchez-Ferro; Julián Benito-León; Alex J Mitchell; Félix Bermejo-Pareja
Journal:  Neuropsychiatr Dis Treat       Date:  2013-01-04       Impact factor: 2.570
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.